13F filer · CIK 1579853
SENZAR ASSET MANAGEMENT, LLC
New York, NY · filing since Q4 2013 · last filing Oct 31, 2018
Reported value
$386.8M
$-72.2M vs prior
Positions
35
New / sold out
8 / 14
Added / reduced
8 / 19
Turnover
27.8%
buys $117.5M · sells $211.6M
Top-10 weight
60.3%
Biggest buys vs Q2 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | EXPRESS SCRIPTS HLDG CO | +297,700 | – | +$21.0M |
| New | ALLERGAN PLC | +58,500 | – | +$13.5M |
| New | MIMEDX GROUP INC | +1,538,456 | – | +$13.2M |
| Added | SANOFI | +331,300 | +30.0% | +$12.7M |
| New | MYLAN N V | +273,500 | – | +$10.4M |
| Added | ANTHEM INC | +75,400 | +52.4% | +$9.4M |
| Added | VALEANT PHARMACEUTICALS INTL | +323,500 | +195.6% | +$7.9M |
| New | ADEPTUS HEALTH INC | +163,700 | – | +$7.0M |
| New | ARRAY BIOPHARMA INC | +627,100 | – | +$4.2M |
| New | SELECT MED HLDGS CORP | +276,400 | – | +$3.7M |
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q2 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ABBOTT LABS | -778,900 | -100.0% | $-30.6M |
| Sold out | BIOGEN INC | -101,600 | -100.0% | $-24.6M |
| Sold out | AMGEN INC | -155,932 | -100.0% | $-23.7M |
| Sold out | HEALTHWAYS INC | -1,827,829 | -100.0% | $-21.1M |
| Sold out | UNIVERSAL HLTH SVCS INC | -114,700 | -100.0% | $-15.4M |
| Reduced | LLYLILLY ELI & CO | -167,300 | -27.8% | $-13.4M |
| Sold out | CENTENE CORP DEL | -172,800 | -100.0% | $-12.3M |
| Sold out | LABORATORY CORP AMER HLDGS | -86,800 | -100.0% | $-11.3M |
| Sold out | ACADIA HEALTHCARE COMPANY IN | -102,400 | -100.0% | $-5.7M |
| Sold out | INTRA CELLULAR THERAPIES INC | -144,624 | -100.0% | $-5.6M |
23 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SANOFISPONSORED ADR | 1,434,600 | $54.8M | 14.17% |
| 2 | LLYLILLY ELI & CO | 434,500 | $34.9M | 9.02% |
| 3 | ANTHEM INCCOM | 219,200 | $27.5M | 7.10% |
| 4 | SHIRE PLCSPONSORED ADR | 137,900 | $26.7M | 6.91% |
| 5 | EXPRESS SCRIPTS HLDG COCOM | 297,700 | $21.0M | 5.43% |
| 6 | AETNA INC NEWCOM | 123,600 | $14.3M | 3.69% |
| 7 | ENDOLOGIX INCCOM | 1,087,700 | $13.9M | 3.60% |
| 8 | ENANTA PHARMACEUTICALS INCCOM | 506,900 | $13.5M | 3.49% |
| 9 | ALLERGAN PLCSHS | 58,500 | $13.5M | 3.48% |
| 10 | MIMEDX GROUP INCCOM | 1,538,456 | $13.2M | 3.41% |
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.